These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3493165)
1. Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP. Steranka LR; Rhind AW Eur J Pharmacol; 1987 Jan; 133(2):191-7. PubMed ID: 3493165 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors. Fuller RW; Hemrick-Luecke SK; Robertson DW Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293 [TBL] [Abstract][Full Text] [Related]
3. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
4. MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administration. Henderson MG; Hemrick-Luecke S; Fuller RW Ann N Y Acad Sci; 1992 May; 648():286-8. PubMed ID: 1379012 [No Abstract] [Full Text] [Related]
5. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102 [TBL] [Abstract][Full Text] [Related]
6. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones. Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420 [TBL] [Abstract][Full Text] [Related]
7. MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats. Hemrick-Luecke SK; Henderson MG; Fuller RW Life Sci; 1992; 50(6):PL31-3. PubMed ID: 1734157 [TBL] [Abstract][Full Text] [Related]
8. In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine. Schmidt CJ; Matsuda LA; Gibb JW Eur J Pharmacol; 1984 Aug; 103(3-4):255-60. PubMed ID: 6333347 [TBL] [Abstract][Full Text] [Related]
9. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM; Gozlan H; Hamon M Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793 [TBL] [Abstract][Full Text] [Related]
11. Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Fuller RW; Hemrick-Luecke S Science; 1980 Jul; 209(4453):305-7. PubMed ID: 7384808 [TBL] [Abstract][Full Text] [Related]
12. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. Fuller RW; Steranka LR Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244 [TBL] [Abstract][Full Text] [Related]
13. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum. Pileblad E; Fornstedt B; Clark D; Carlsson A J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901 [TBL] [Abstract][Full Text] [Related]
16. Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Fuller RW; Hemrick-Luecke SK Neuropharmacology; 1982 May; 21(5):433-8. PubMed ID: 7110533 [TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Corsini GU; Zuddas A; Bonuccelli U; Schinelli S; Kopin IJ Life Sci; 1987 Mar; 40(9):827-32. PubMed ID: 2434820 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW; Robertson DW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [TBL] [Abstract][Full Text] [Related]
19. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice. Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630 [TBL] [Abstract][Full Text] [Related]